Large-Scale Freezing of Biologics: Understanding Protein and Solute Concentration Changes in a Cryovessel—Part I - What really happens to protein and solute concentrations during bulk freezing

ADVERTISEMENT

Large-Scale Freezing of Biologics: Understanding Protein and Solute Concentration Changes in a Cryovessel—Part I
What really happens to protein and solute concentrations during bulk freezing at different rates.


BioPharm International
Volume 23, Issue 6

REFERENCES

1. Singh SK, Kolhe P, Wang W, Nema S. Large-scale freezing of biologics—a practitioner's review, part one: fundamental aspects. Bioprocess Int. 2009;7(10):32–44.

2. Singh SK, Kolhe P, Wang W, Nema S. Large-scale freezing of biologics—a practitioner's review. Part two: practical advice. Bioprocess Int. 2009;7(11):34–42.

3. Singh SK. Storage considerations as part of the formulation development program for biologics. Am Pharma Rev. 2007;10(3):26–33.

4. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505–23.

5. Lashmar UT, Vanderburgh M, Little SJ. Bulk freeze–thawing of macromolecules effects of cryoconcentration on their formulation and stability. Bioprocess Int. 2007;5(6):44–54.

6. Tschoepe M, Schmidt R. Impact of freeze/thaw processing on monoclonal antibody stability. Bioprocess International Conference. Vienna, Switzerland. April 2008.

7. Webb SD, Webb JN, Hughes TG, Sesin DF, Kincaid AC. Freezing biopharmaceutical using common techniques and the magnitude of bulk scale freeze-concentration. Bioprocess Int. 2002;15(5):22–34.

8. Wisniewski R, Wu VL. Large-scale freezing and thawing of biopharmaceutical products. In: Avis KE, Wu VL, editors. Biotechnology and biopharmaceutical manufacturing, processing, and preservation. Interpharm Press, Buffalo Grove, IL. 1996:7–60.

9. Zippelius R. Untersuchung zum Enifrier- und Aufauverhalten Pharmazeutischer Humanproteinlosungen im Grossmasstab. (Investigation of Freezing and Thawing Process of Human Pharmaceutical Protein Solutions at Large Scale). PhD Thesis (in German), Ludwig-Maximilians University, Munich, 2002.

10. Kolhe P, Badkar A. Protein and Solute Distribution in Drug Substance Containers During Frozen Storage As Well As Post-Thawing: A Tool To Understand and Define Freezing-Thawing Parameters in Biotechnology Process Development Submitted 2009.

11. Maity H, Karkaria C, Davagnino J. Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze-thawing of fibroblast growth factor 20. Int J Pharm. 2009;378(1-2):122-135.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines
Source: BioPharm International,
Click here